Log In
Print this Print this

OncoScint PR (CYT-356)

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
Description mAb conjugated with Indium-III and targeted to the prostate-specific membrane antigen (PSMA)
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetect prostate cancer cells in blood; image prostate tumors; Preoperative evaluation of prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today